EP Patent

EP1900727A1 — Aminopyridine derivatives as kinase inhibitors

Assigned to Cellzome GmbH · Expires 2008-03-19 · 18y expired

What this patent protects

The invention relates to compounds of formula (I) wherein T 1 and T 2 have the meaning as cited in the description and the claims. Said compounds are useful as Itk protein kinase inhibitors for the treatment or prophylaxis of immunological, inflammatory or allergic disord…

USPTO Abstract

The invention relates to compounds of formula (I) wherein T 1 and T 2 have the meaning as cited in the description and the claims. Said compounds are useful as Itk protein kinase inhibitors for the treatment or prophylaxis of immunological, inflammatory or allergic disorders. The invention also relates to pharmaceutical compositions including said compounds, the preparation of such compounds as well as the production of and use as medicaments.

Drugs covered by this patent

Patent Metadata

Patent number
EP1900727A1
Jurisdiction
EP
Classification
—
Expires
2008-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Cellzome GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.